Literature DB >> 25385326

Complement C5-deficient mice are protected from seizures in experimental cerebral malaria.

Susan C Buckingham1, Theresa N Ramos, Scott R Barnum.   

Abstract

Studies have demonstrated that the membrane attack complex (MAC) of complement can evoke seizures when injected directly into rodent brain. In the course of studies that examine the role of complement in the development of experimental cerebral malaria (ECM), we observed fewer seizures in mice deficient in C5, a component required for MAC formation. To determine if the MAC contributed to the tonic-clonic seizures characteristic of ECM, we performed long-term video-electroencephalography (EEG) on C5(-/-) mice with Plasmodium berghei ANKA-induced cerebral malaria and observed significantly reduced spike and seizure frequency compared to wild-type mice. Our data suggest a role for the MAC in malaria-induced seizures and that inhibition of the terminal complement pathway may reduce seizures and seizure-related neurocognitive deficits. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Plasmodium berghei zzm321990ANKA; Terminal complement pathway

Mesh:

Substances:

Year:  2014        PMID: 25385326      PMCID: PMC4285666          DOI: 10.1111/epi.12858

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

Review 1.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

3.  Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Xianzhen Hu; Oliver Billker; Julian C Rayner; Malika Ahras; Jillian E Wohler; Scott R Barnum
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

4.  Deletion of carboxypeptidase N delays onset of experimental cerebral malaria.

Authors:  M M Darley; T N Ramos; R A Wetsel; S R Barnum
Journal:  Parasite Immunol       Date:  2012 Aug-Sep       Impact factor: 2.280

5.  The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Neal S Young; Jörg Schubert; Robert A Brodsky; Gerard Socié; Petra Muus; Alexander Röth; Jeffrey Szer; Modupe O Elebute; Ryotaro Nakamura; Paul Browne; Antonio M Risitano; Anita Hill; Hubert Schrezenmeier; Chieh-Lin Fu; Jaroslaw Maciejewski; Scott A Rollins; Christopher F Mojcik; Russell P Rother; Lucio Luzzatto
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 6.  Malaria.

Authors:  Nicholas J White; Sasithon Pukrittayakamee; Tran Tinh Hien; M Abul Faiz; Olugbenga A Mokuolu; Arjen M Dondorp
Journal:  Lancet       Date:  2013-08-15       Impact factor: 79.321

7.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

8.  Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain.

Authors:  Claudia Casarsa; Ada De Luigi; Mario Pausa; Maria Grazia De Simoni; Francesco Tedesco
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

9.  Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.

Authors:  Hani Kim; Laura K Erdman; Ziyue Lu; Lena Serghides; Kathleen Zhong; Aggrey Dhabangi; Charles Musoke; Craig Gerard; Christine Cserti-Gazdewich; W Conrad Liles; Kevin C Kain
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

10.  C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.

Authors:  Samir N Patel; Joanne Berghout; Fiona E Lovegrove; Kodjo Ayi; Andrea Conroy; Lena Serghides; Gundula Min-oo; D Channe Gowda; J Vidya Sarma; Daniel Rittirsch; Peter A Ward; W Conrad Liles; Philippe Gros; Kevin C Kain
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

View more
  8 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Authors:  Dennis Dlugos; Greg Worrell; Kathryn Davis; William Stacey; Jerzy Szaflarski; Andres Kanner; Sridhar Sunderam; Mike Rogawski; Patrice Jackson-Ayotunde; Tobias Loddenkemper; Beate Diehl; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

3.  Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream.

Authors:  Angelika Hoffmann; Johannes Pfeil; Julieta Alfonso; Felix T Kurz; Felix Sahm; Sabine Heiland; Hannah Monyer; Martin Bendszus; Ann-Kristin Mueller; Xavier Helluy; Mirko Pham
Journal:  PLoS Pathog       Date:  2016-03-10       Impact factor: 6.823

4.  A Murine Model to Study Epilepsy and SUDEP Induced by Malaria Infection.

Authors:  Paddy Ssentongo; Anna E Robuccio; Godfrey Thuku; Derek G Sim; Ali Nabi; Fatemeh Bahari; Balaji Shanmugasundaram; Myles W Billard; Andrew Geronimo; Kurt W Short; Patrick J Drew; Jennifer Baccon; Steven L Weinstein; Frank G Gilliam; José A Stoute; Vernon M Chinchilli; Andrew F Read; Bruce J Gluckman; Steven J Schiff
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

5.  Inferior Colliculus Transcriptome After Status Epilepticus in the Genetically Audiogenic Seizure-Prone Hamster GASH/Sal.

Authors:  Sandra M Díaz-Rodríguez; Daniel López-López; Manuel J Herrero-Turrión; Ricardo Gómez-Nieto; Angel Canal-Alonso; Dolores E Lopéz
Journal:  Front Neurosci       Date:  2020-05-26       Impact factor: 4.677

6.  Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.

Authors:  Klebea Carvalho; Nicole D Schartz; Gabriela Balderrama-Gutierrez; Heidi Y Liang; Shu-Hui Chu; Purnika Selvan; Angela Gomez-Arboledas; Tiffany J Petrisko; Maria I Fonseca; Ali Mortazavi; Andrea J Tenner
Journal:  J Neuroinflammation       Date:  2022-07-11       Impact factor: 9.587

7.  Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.

Authors:  Xiaoyan Fu; Jiyu Ju; Zhijuan Lin; Weiling Xiao; Xiaofang Li; Baoxiang Zhuang; Tingting Zhang; Xiaojun Ma; Xiangyu Li; Chao Ma; Weiliang Su; Yuqi Wang; Xuebin Qin; Shujuan Liang
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

Review 8.  Soluble Membrane Attack Complex: Biochemistry and Immunobiology.

Authors:  Scott R Barnum; Doryen Bubeck; Theresa N Schein
Journal:  Front Immunol       Date:  2020-11-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.